Published in J Clin Gastroenterol on June 01, 1990
Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut (1996) 2.79
Is use of PPIs related to increased intraepithelial lymphocytes in the colon? Dig Dis Sci (2012) 1.45
Diagnosis and management of microscopic colitis. World J Gastroenterol (2008) 1.24
Diagnosis and management of microscopic colitis: current perspectives. Clin Exp Gastroenterol (2014) 1.15
Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut (2000) 1.14
Complications of collagenous colitis. World J Gastroenterol (2008) 1.13
Resolution of paraneoplastic collagenous enterocolitis after resection of colon cancer. Can J Gastroenterol (2006) 1.06
Recent advances in diagnosis and treatment of microscopic colitis. Ann Gastroenterol (2011) 0.84
Long-term natural history and complications of collagenous colitis. Can J Gastroenterol (2012) 0.81
Noninfectious colitides: collagenous colitis, lymphocytic colitis, diversion colitis, and chemically induced colitis. Clin Colon Rectal Surg (2007) 0.80
Celiac disease and microscopic colitis: a report of 4 cases. World J Gastroenterol (2011) 0.80
Diagnosis and management of microscopic colitis. Can Fam Physician (2003) 0.78
NOD2/CARD15 gene polymorphisms are not associated with collagenous colitis. Int J Colorectal Dis (2006) 0.78
Low bone mass in microscopic colitis. BMC Gastroenterol (2011) 0.75
Optimal management of collagenous colitis: a review. Clin Exp Gastroenterol (2016) 0.75
Helicobacter pylori and atrophic gastritis: importance of the cagA status. J Natl Cancer Inst (1995) 6.07
Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol (1998) 5.77
Long-term sequelae of Helicobacter pylori gastritis. Lancet (1995) 4.26
Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med (1996) 4.11
Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med (1994) 4.00
Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins. Lancet (1994) 3.69
Cervical lymph node metastasis: assessment of radiologic criteria. Radiology (1990) 3.24
[Diversity of complaints in manifesting carcinoma of the gallbladder]. Ned Tijdschr Geneeskd (2007) 3.10
Randomised trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet (1998) 2.84
Clostridial toxin in faeces of healthy infants. Lancet (1978) 2.58
Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. Am J Gastroenterol (1999) 2.33
Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol (1997) 2.17
Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety. Am J Gastroenterol (1995) 2.12
Oral cimetidine in reflux esophagitis: a double blind controlled trial. Gastroenterology (1978) 2.07
Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer (1995) 2.00
Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum. Gut (1992) 1.96
Seroconversion for Helicobacter pylori. Lancet (1993) 1.88
Time trends in gastric carcinoma: changing patterns of type and location. Am J Gastroenterol (1992) 1.88
Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol (1996) 1.86
Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Lancet (1987) 1.83
Analysis of the lympho-plasmacytic infiltrate in Crohn's disease with special reference to identification of lymphocyte-subpopulations. Gut (1976) 1.83
Update in pulmonary carcinoid tumors: a review article. Ann Surg Oncol (2003) 1.82
Double-blind comparison of slow-release 5-aminosalicylate and sulfasalazine in remission maintenance in ulcerative colitis. Gastroenterology (1988) 1.75
Comparison of the efficacy and safety of 1.5 compared with 3.0 g oral slow-release mesalazine (Pentasa) in the maintenance treatment of ulcerative colitis. Dutch Pentasa Study Group. Eur J Gastroenterol Hepatol (1995) 1.74
Helicobacter pylori: a true carcinogen? Eur J Gastroenterol Hepatol (1998) 1.72
Impaired anamnestic cellular immune response in patients with Crohn's disease. Gut (1975) 1.65
Surveillance in Barrett's oesophagus: a critical reappraisal. Scand J Gastroenterol Suppl (2002) 1.63
Parietal cell protrusions and fundic gland cysts during omeprazole maintenance treatment. Hum Pathol (2000) 1.62
Helicobacter pylori and the birth cohort effect: evidence of a continuous decrease of infection rates in childhood. Am J Gastroenterol (1997) 1.62
Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection. Aliment Pharmacol Ther (1998) 1.61
Loss of E-cadherin expression in early gastric cancer. Histopathology (1999) 1.59
Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol (1998) 1.54
Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Eur J Gastroenterol Hepatol (1996) 1.52
Vasculitis due to gemcitabine. Lung Cancer (2002) 1.50
Classification of gastric carcinoma using the Goseki system provides prognostic information additional to TNM staging. Cancer (1999) 1.50
Rapid quantitative assessment of gastric corpus atrophy in tissue sections. J Clin Pathol (2001) 1.50
Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications. Gut (1991) 1.50
The applicability of a keratin 7 monoclonal antibody in routinely Papanicolaou-stained cytologic specimens for the differential diagnosis of carcinomas. Am J Clin Pathol (1994) 1.47
The effect of calcium on the secretion of factor VIII-related antigen by cultured human endothelial cells. Biochim Biophys Acta (1983) 1.45
Diagnostic accuracy of fiberendoscopy in the detection of upper intestinal malignancy. A follow-up analysis. Gastroenterology (1977) 1.44
Epidemiological, clinical, and histological characteristics of intestinal metaplasia at the oesophagogastric junction compared to short segments of columnar-lined oesophagus. Eur J Gastroenterol Hepatol (2001) 1.43
The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Scand J Gastroenterol Suppl (2001) 1.43
Stage is a better prognostic indicator than morphologic subtype in primary noncutaneous T-cell lymphoma. Am J Clin Pathol (1990) 1.41
Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol (1995) 1.39
[Oesophageal endoscopic ultrasound with fine-needle aspiration biopsy in the staging of non-small-cell lung carcinoma; results from 43 patients]. Ned Tijdschr Geneeskd (2006) 1.39
Reliable gastric tonometry after coronary artery surgery: need for acid secretion suppression despite transient failure of acid secretion. Intensive Care Med (1998) 1.38
[Virilisation due to an ovarian mucinous cystadenoma]. Ned Tijdschr Geneeskd (2007) 1.38
[Diagnosis of lymph node metastasis of head-neck carcinomas]. Ned Tijdschr Geneeskd (1995) 1.38
Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol (1993) 1.37
Percutaneous endoscopic gastrostomy: complications and suggestions to avoid them. Eur J Gastroenterol Hepatol (2001) 1.37
Third degree obstetric perineal tears: risk factors and the preventive role of mediolateral episiotomy. Br J Obstet Gynaecol (1997) 1.35
Distribution of four polymorphisms in the tumour necrosis factor (TNF) genes in patients with inflammatory bowel disease (IBD). Clin Exp Immunol (1996) 1.33
Importance of the fiberoptic endoscope cleaning procedure for detection of Helicobacter pylori in gastric biopsy specimens by PCR. J Clin Microbiol (1994) 1.32
Treatment of reflux oesophagitis with ranitidine. Gut (1983) 1.29
Dendritic cells and scavenger macrophages in chronic inflammatory bowel disease. Gut (1989) 1.29
Veiled cells in chronic idiopathic inflammatory bowel disease. Clin Exp Immunol (1984) 1.29
CT before and after ERCP: detection of pancreatic pseudotumor, asymptomatic retroperitoneal perforation, and duodenal diverticulum. Gastrointest Endosc (1997) 1.28
Oral lipomas with osseous and chondrous metaplasia; report of two cases. J Oral Pathol (1982) 1.28
HLA-DRB1*03, but not the TNFA -308 promoter gene polymorphism, confers protection against fistulising Crohn's disease. Immunogenetics (1998) 1.25
Lack of lymphangiogenesis during breast carcinogenesis. J Clin Pathol (2004) 1.25
Esophagopleural fistula treated endoscopically with argon beam electrocoagulation and clips. Gastrointest Endosc (1999) 1.24
Human papillomavirus in false negative archival cervical smears: implications for screening for cervical cancer. J Clin Pathol (1995) 1.21
Large mononuclear Ia-positive veiled cells in Peyer's patches. I. Isolation and characterization in rat, guinea-pig and pig. Immunology (1983) 1.20
Large mononuclear Ia-positive veiled cells in Peyer's patches. II. Localization in rat Peyer's patches. Immunology (1983) 1.20
Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis. Gastroenterology (1990) 1.19
Lymph node staging in patients with clinically negative neck examinations by ultrasound and ultrasound-guided aspiration cytology. Am J Surg (1991) 1.18
Neutrophil cytoplasmic antibodies (p-ANCA) in ulcerative colitis. J Clin Pathol (1994) 1.17
The prognostic value of neuroendocrine differentiation in adenocarcinoma of the prostate in relation to progression of disease after endocrine therapy. J Urol (1997) 1.16
Detection of factor VIII/coagulant antigen in human liver tissue. Nature (1983) 1.16
Role of Helicobacter pylori in the pathogenesis of atrophic gastritis. Scand J Gastroenterol Suppl (1997) 1.14
Non-lymphoid and lymphoid cells in acute, chronic and relapsing experimental colitis. Clin Exp Immunol (1995) 1.11
Treatment failure of norfloxacin against Campylobacter pylori and chronic gastritis in patients with nonulcerative dyspepsia. Antimicrob Agents Chemother (1989) 1.11
[Differences between men and women in the composition of atherosclerotic plaque, as an explanation for the lower success rate of carotid endarterectomy in women]. Ned Tijdschr Geneeskd (2008) 1.10
Review article: the development of atrophic gastritis--Helicobacter pylori and the effects of acid suppressive therapy. Aliment Pharmacol Ther (1995) 1.10
Ankylosing spondylitis and inflammatory bowel disease. I. Prevalence of inflammatory bowel disease in patients suffering from ankylosing spondylitis. Ann Rheum Dis (1978) 1.09
Primary retroperitoneal mucinous cystadenoma with sarcoma-like mural nodule : a case report and review of the literature. Virchows Arch (2007) 1.09
Von Willebrand factor in the vessel wall mediates platelet adherence. Blood (1985) 1.09
Ankylosing spondylitis and inflammatory bowel disease. II. Prevalence of peripheral arthritis, sacroiliitis, and ankylosing spondylitis in patients suffering from inflammatory bowel disease. Ann Rheum Dis (1978) 1.09
Safety and efficacy of multiband mucosectomy in 1060 resections in Barrett's esophagus. Endoscopy (2011) 1.09
Effect of oral omeprazole on serum gastrin and serum pepsinogen I levels. Gastroenterology (1984) 1.08
Does color vision deficiency in the endoscopist influence the accuracy of endoscopic diagnosis? An anonymous study with Dutch gastrointestinal endoscopists. Endoscopy (1994) 1.07
Occult metastatic neck disease: detection with US and US-guided fine-needle aspiration cytology. Radiology (1991) 1.06
Elevated lesions in the duodenal bulb caused by heterotopic gastric mucosa. Radiology (1980) 1.05
Anorectal function investigations in incontinent and continent patients. Differences and discriminatory value. Dis Colon Rectum (1990) 1.04
Omeprazole and accelerated onset of atrophic gastritis. Gastroenterology (2000) 1.04
Combined gastric and oesophageal 24-hour pH monitoring and oesophageal manometry in patients with reflux disease, resistant to treatment with omeprazole. Aliment Pharmacol Ther (1990) 1.04
Role of animal models for the pathogenesis and treatment of inflammatory bowel disease. Scand J Gastroenterol Suppl (1997) 1.04
Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce tumor necrosis factor alpha and beta in patients with inflammatory bowel disease and healthy controls. Scand J Gastroenterol (1995) 1.04
Selective preoperative endoscopic retrograde cholangiopancreatography in laparoscopic biliary surgery. Br J Surg (1995) 1.04
A review on treatment of bleeding peptic ulcer: a collaborative task of gastroenterologist and surgeon. Scand J Gastroenterol Suppl (1996) 1.02
Histocompatibility antigens and other genetic markers in ankylosing spondylitis and inflammatory bowel diseases. J Immunogenet (1977) 1.01
Genetic markers in clinically well defined patients with ulcerative colitis (UC). Clin Exp Immunol (1999) 1.01